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disease difficult?
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Summary
The article reflects the reasons for the scarcity of patient-inclusive projects in Alzheimer’s disease psycho-
social research. Among the prejudices concerning research methods the authors identify and examine:
1. the expectation to obtain rich data while involving as little means as possible,
2. the belief that investigating experiences of AD patients poses specific challenges to the researcher and 
3. the conviction that the scientist’s role is abused by such challenges. The attitude towards involving peo-
ple with AD in research is also shaped by fear and stigma connected with the disease. The need to apply 
a metaclinical perspective is suggested.
Alzheimer’s disease / dementia / research / ethical aspects
INTRODUCTION
In a text published by Cotrell and Schulz in 
1993 [1], the authors point to the fact that our 
understanding of Alzheimer’s disease (AD) 
has become increasingly biomedical and the 
experience of people with AD tends to be at-
tributed solely to the disease process. What is 
more, “in the majority of research on AD, the 
afflicted person is viewed as a disease entity 
to be studied rather than someone who can 
directly contribute to our understanding of 
the illness and its course” [1]. Since the time 
of Cotrell’s and Schultz’s publication, the need 
to include patients with Alzheimer’s disease 
as equal participants in research as well as to 
allow them to speak about their experiences 
and needs has been underlined many times 
[2 ,3, 4, 5]. Practical approaches to dementia 
care, developed in the last two decades, have 
taken into consideration models of caregiving 
other than the organic model or “the standard 
paradigm” as Kitwood calls it [3]. Such frames 
for interventions perceive the process of devel-
oping an empathic, supportive relationship as 
an end in itself [6, 7]. However, academic re-
search within such patient-inclusive approach-
es still remains scarce. Even in the field of clin-
ical trials of new drugs, the involvement of pa-
tients with AD is insufficient: in the UK, less 
than 1% of people with this condition are in-
volved in trials of experimental therapies. [8] 
This number is far below the average percentage 
of cancer patients participating in clinical trials. 
Still, there are even fewer people with AD engaged 
in research concerning their psychosocial situation. 
Recent research agendas on neurodegenera-
tive diseases, such as The European Dementia 
Research Agenda, still stress the need for com-
bining both approaches – the biomedical and 
the psychosocial one – in order to provide bet-
ter care.
Although psychosocial research in the field of 
Alzheimer’s disease has been developing for sev-
eral decades now, there still remains a lot to dis-
42 Katarzyna Hess-Wiktor, Małgorzata Opoczyńska
Archives of Psychiatry and Psychotherapy, 2012; 2 : 41–47
cover and many questions demand an answer. 
There is also an unexplored area of the questions 
that have not yet been asked. Among these an 
especially neglected area of research is the expe-
rience of people with AD [9, 10]. Personal mean-
ings give us knowledge and understanding that 
cannot be obtained through second-person ac-
counts or triangulation methods. Therefore, it is 
the person with AD who should be asked: how 
does cognitive loss impact him/her? How does 
he/she perceive the change brought by the dis-
ease? How does he/she cope with his/her disa-
bilities?
In order to answer the title question – why 
is research involving people with dementia so 
difficult? – this paper will pinpoint the tacit as-
sumptions about Alzheimer’s disease held by re-
searchers and healthcare professionals that im-
pede including people with AD into research. 
We seem to know what issues need to be con-
sidered, but we have not posed the crucial ques-
tion: why have they not been yet?
Scientific research is an action, which has its 
premises in the will to act and in the judgments 
concerning the aim and the motive of the act. 
[11] We should then consider both the reasons of 
the unwillingness to involve people with Alzhe-
imer’s disease in research and the presupposi-
tions that such attitude stems from. Firstly, how-
ever, the obstacles in including patients with AD 
into research have to be summarized.
OBsTACLEs IN AD REsEARCH
First of all, one of the most obvious obstacles in 
psychosocial AD research seems to be the cogni-
tive impairment of the patients, especially in the 
advanced phases of the disease. As states de Boer 
et al. “For long it was assumed that data collect-
ed from people with dementia themselves were 
unreliable because of their cognitive impairment, 
and therefore unusable” [12]. The fact that com-
munication with people with AD is considered 
hampered in comparison to that with healthy 
people leads to strong objections to the validity 
of the data. On speaking with an AD patient, one 
asks himself whether the questions were proper-
ly understood and the responses adequate and 
logical. In case of people with a neurodegenera-
tive disease, the impairment of reasoning, judg-
ment, decision-making and language too often 
prompts the listener to deny any logic and rea-
son in the interlocutor’s statements.
Secondly, there are serious ethical doubts in re-
search involving AD patients. They are strong-
ly connected with cognitive impairment of the 
subjects – if there is no mutual understanding, 
the influence on the vulnerable research partic-
ipant is considered to be more harmful. One of 
the most vital ethical concerns is the eligibility of 
AD patients to consciously consent to research 
participation. This issue has been discussed in 
many places and the use of decision-making 
surrogates’ consent or continuous verification 
of agreement has been suggested [13].
Thirdly, data collection within AD patients is 
difficult due to specific requirements of the re-
searched group. The researcher has to apply an 
individual approach to every patient adjusting 
not only the design and setting of the data col-
lection but also his/her emotional attitude to-
wards the subject [9]. As with any clinical pop-
ulation, access to the potential participant is lim-
ited and one has to take into consideration the 
expectation of the patient to get something in re-
turn for his or her contribution – at least some 
professional advice. What is more, important ob-
stacles also lie in the financial and socio-cultur-
al conditions of the patient’s country. Access to 
the patients is strongly linked to the develop-
ment of professional dementia services and the 
knowledge general practitioners (GPs) possess. 
In the countries where dementia care is poor-
ly developed, as in Poland, information and aid 
for AD patients is difficult to access and is lim-
ited to the largest cities [14]. Therefore, a lot of 
potential research participants remain undiag-
nosed and deprived of medical and psychoso-
cial aid and often they and their families are left 
alone. Not being able to receive an aid and the 
lack of development of such aid harm both the 
patient and the research on the disease; it’s a vi-
cious circle.
The fourth group of obstacles in AD care de-
rives from the diagnostic difficulties concerning 
the illness. Not only are the diagnostic facilities 
hard to reach, but also the diagnosis of Alzheim-
er’s disease itself leaves significant doubt. Sever-
al factors contribute to this state [9, 15]:
1. During the patient’s life the diagnosis is only 
probable, never definite.
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2. GPs often have little knowledge about the di-
agnostic criteria.
3. GPs assign the first symptoms to “memory 
problems” of normal aging.
4. Patients may be denying the existence of 
symptoms thus hindering the discovery of 
the disease.
5. As a consequence of the above points, the di-
agnosis takes place late in the progress of the 
illness, often at a stage when verbal communi-
cation with the patient is severely disturbed.
6. Patients informed about the disease may 
be denying its existence as a natural coping 
mechanism.
7. The reaction to the diagnosis of Alzheimer’s 
disease involves strong negative emotions.
Having the diagnosis revealed may cause con-
siderable distress and conducting research at 
this moment raises the question of the balance of 
benefits and potential harm to the patient [16].
There is also the problem of anosognosia co-
occurring with Alzheimer’s disease. Even if the 
patient was informed about the diagnosis, he 
or she may be at some point unaware of the ill-
ness [17], in which case investigating their ex-
perience of Alzheimer’s disease may be diffi-
cult, as the issue would be perceived only by 
the researcher, not the participant.
However, these obstacles are due to certain as-
sumptions we have about Alzheimer’s disease 
and the possibilities of their scientific investiga-
tion. The presuppositions or prejudices (as Gad-
amer understands the notion [18]) that underlie 
our attitude towards involving people with AD 
in research are worthy further consideration.
PREJUDICEs UNDERLyING THE OBsTACLEs
In general, our prejudices towards the research 
in question can be divided into those concerning 
the specificity of Alzheimer’s disease and those 
resulting from methodological scientific require-
ments. Interestingly, it seems that it is not the 
subject but the method that limits researchers 
more in their quest for knowledge on the expe-
rience of having Alzheimer’s disease.
Among presuppositions concerning research 
methods are the following:
1. The expectation to maintain “economic” bal-
ance, i.e. to obtain rich data while involving 
as little means as possible,
2. The belief that investigating experiences of 
AD patients poses specific challenges to the 
researcher,
3. The conviction that challenges mentioned 
above abuse the role of the scientist who 
should remain unengaged with the studied 
subject.
Let us carefully consider each of these preju-
dices:
1. The first mentioned obstacle, cognitive im-
pairment and the following communication 
difficulties, seems to be an objective hardship 
in involving AD patients in research. But is it 
really so? Beuscher and Grando point to the 
need of collecting larger samples of data and 
a more thorough analysis, as well as multi-
ple data collection sessions and careful ad-
justment to the respondent’s demands [9]. Ny-
gård [19] emphasizes the benefits of conduct-
ing research interviews in a natural context, 
which will enhance recalling memories and 
limit distractions. What is more, AD research 
often requires a multi-method approach. As 
Cotrell and Schulz state: “The combination of 
data derived from proxy reports, behavioral 
observations, and clinical assessment is like-
ly to provide a better indication of excess dis-
ability than any one method alone” [1]. It is 
then not the question of the impairment itself, 
but of the means to take it into account be-
cause the time and cost spent on research in-
volving Alzheimer’s disease patients exceeds 
that spent on studying subjects not suffering 
from a neurodegenerative disease, such as the 
patient’s caregiver. Perhaps the cause of scar-
city of research with AD patients is the con-
venience of researchers? This is not restrict-
ed only to the financial or logistical aspect, 
but entails also the psychological comfort of 
the investigator. After all, contact with a pa-
tient suffering from AD may not be a pleasant 
one: the respondent may behave irrationally, 
have emotional outbursts, repeat answers or 
slow down the procedure. In addition, when 
speaking with a person with AD, we usual-
ly tend to perceive his or her impairment and 
illness symptoms more vividly than the as-
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pects of the interaction we consider “normal”. 
Thus, being more sensitive to misunderstand-
ing than to understanding, we may exclude 
potentially valuable data too hastily.
2. Next, there is the issue of personal qualities 
needed to study AD patients. Nygård points 
to two important features of the research-
er’s personality which are required in inves-
tigations concerning neurodegenerative dis-
eases: “flexibility and the ability to impro-
vise” [19]. Because of the ethical considera-
tions mentioned before, both the project and 
the researcher are also required to commit 
to high ethical standards. Maybe withdraw-
ing from AD patient research is just a “safer 
way” of investigating Alzheimer’s disease? 
Isn’t it an approach which does not test the 
value and skills of the scientist as much as 
talking to the patient would?
3. Moreover, the researcher is challenged by get-
ting involved in a relation with the inform-
ant, which happens for example when a mul-
ti-stage research – advised in the study of AD 
patients – is being carried out [19]. On the one 
hand, the participant is more eager to engage 
in a study with a person he/she knows, on the 
other hand – this contradicts the expectation 
that the researcher should not connect with 
the subject personally. But is it really so? May-
be our expectations towards the role of the sci-
entist in psychosocial AD research should be 
reconsidered?
In fact, the methodological procedures scien-
tists are committed to – especially those work-
ing within the positivist, nomothetic paradigm 
– tend to exclude people with Alzheimer’s. The 
notions of validity and reliability need to be re-
considered, as research on patients with neu-
rodegenerative diseases has shown significant 
instability of their responses over time and 
the tendency to answer question in a way that 
would satisfy the researcher [4]. Idiograph-
ic approach and qualitative methods seem to 
be more flexible as for the adaptability to the 
needs of AD patient research [10]. Neverthe-
less, it has to be highlighted that this problem 
is only a vivid example of more significant 
methodological issues like: what comes first 
– the subject or the method? What do we gain 
and what do we lose trying to fulfill method-
ological standards in a clinical population? 
What do we want to discover in a particular 
AD research project – the common norms and 
rules of behavior or the unique personal ex-
periences?
Nevertheless, it is not only methodology that 
hampers involving people with AD in research. 
Understanding the prejudices we hold against 
Alzheimer’s disease itself is crucial to finding a 
way to overcome the difficulties in leading in-
vestigations including AD patients. As members 
of society and people who might potentially be 
affected, researchers too are exposed to stigma-
tizing beliefs on neurodegenerative diseases. 
Two features of our attitudes towards Alzheim-
er’s disease seem to be essential:
FEAR
stigma
Although these two presuppositions seem to 
be related, such a distinction allows a more thor-
ough consideration of impediments in AD re-
search:
1. Perhaps what underlies most of the concerns in 
research involving AD patients is fear. Kitwood 
asks: “Is it that people with dementia were con-
sidered to have no experiences? Is it that their 
subjective world was assumed to be so bizarre 
and disordered that it could not be discussed 
in the categories of rational discourse? Is it that 
they were no longer deemed to be persons, and 
thus not worthy of consideration? Whatever ar-
gument is given for this flight from intersub-
jective engagement, it bears the marks of a ra-
tionalization of fear” [3].
 2. A specific stigma is connected to Alzheim-
er’s disease and the social construction of the 
affected patients is sometimes compared to 
those of “zombies” [20]. Firstly, it is so be-
cause of the insufficient knowledge we have 
about this illness. The problematic behavior 
of people with AD and other diseases involv-
ing dementia may “challenge social norms re-
garding appropriate conduct” [21] – we come 
across unexpected, irrational reactions and en-
counter communication difficulties. Yet, what 
we know is that “Alzheimer’s disease is a pro-
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gressive and disabling illness leading to de-
pendence and a need for constant support” 
[22]. We can only be sure it will get worse. 
Secondly, the experience of multiple and pro-
gressive loss of memory, social status and 
identity or the so called “death before death” 
seems horrifying to people that come across 
this kind of disease [23].
It is a state we cannot and fear to imagine, an 
experience totally strange to a healthy individ-
ual. The stigma described above dehumanizes 
people with Alzheimer’s disease and, by doing 
so, contributes to their preclusion from research 
participation. It is also reflected in the aversion 
towards naming the patient’s condition: “Alzhe-
imer’s disease” and “dementia” bear a strong 
negative value [23]. When talking to people with 
AD or their caregivers, these terms are often re-
placed by the expression “memory problems”. 
Is it possible to eradicate the fear surrounding 
Alzheimer’s disease, at least within the academ-
ic research context? If we realize what we fear, 
will this emotion disappear? Is the developing 
research minimizing the anxiety towards AD?
THE CLINICAL AND THE METACLINICAL  
PERsPECTIvE
The prejudices described above contribute 
to a specific perspective on Alzheimer’s dis-
ease research that eliminates the person from 
the picture, leaving the researcher focused 
on the illness itself. Victor Frankl’s (1950) dis-
tinction of the clinical and metaclinical per-
spective shed light to the situation in ques-
tion [24]. [Tab. 1]. The clinical perspective in 
AD research results in a reductionism of the 
kind that identifies a person with the diagno-
sis given to him/her. Such a process Frankl calls 
“nihilism” [25]. If the researcher is focused on 
obtaining information he/she seeks and which 
may be considered reliable; if such informa-
tion is to be used in planning further actions, 
e.g. therapy, then a logical consequence is over-
looking people with advanced Alzheimer’s dis-
ease as those not providing reliable information. 
It seems that current AD research is limited by 
such a narrow clinical perspective.
On the contrary, the metaclinical perspective 
allows and encourages researchers to involve 
people with Alzheimer’s disease into research 
because it encompasses more than only seeking 
for scientific results. The relation, emphasized in 
the metaclinical perspective, is not a means to an 
end, but is a value itself. Metaclinical research is 
not an action defined by its aim, e.g. curing, but 
is due to a principle. Such an approach in AD re-
search is founded on a personalistic treatment of 
the subjects or patients, who – as persons – can-
not be reduced to what they have (e.g. cogni-
tive impairments). This perspective is related to 
the well-known framework of person-centered 
care, but it is rather a challenge for researchers 
Table 1. The clinical and metaclinical perspective – comparison
Clinical perspective Metaclinical perspective
Focus  
of research Removing symptoms of the illness Understanding the person
Aim  
of research
Description, explanation and prognosis of phenom-
enons based on the change dynamics and their de-
terminants
Understanding; transcending what is given towards 
what is not given (the metaclinical), i.e. sense  
and meaning 
Research  
subject
The psychophysical organism and its functions/dys-
functions along with their enhancement/relief
The person as a physical, psychological and spiritual 
entity; reducing the person to an illness and focusing 
on the dysfunctions is considered unethical
Actions  
undertaken
Diagnosing, discovering symptoms dynamics,  
their explanation, prognosis and curing
Establishing a relation with the ill person; not only 
communicating
Role of the  
researcher Observer of a predefined research subject Participant of the research
Research 
procedure
The research subject is supposed to provide the  
researcher with information which is then evaluated 
by the researcher as reliable or not reliable, based 
on acknowledged criteria 
The research shapes the attitude of persons  
involved in the procedure; outcomes are not  
subject to evaluation based on the amount  
and quality of gathered information
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and their attitudes than a policy or guidelines 
for application.
The difference between a clinical and meta-
clinical perspective clearly illustrates an exam-
ple from a research project of Polish family car-
egivers of people with Alzheimer’s disease of 
one of the authors:
Krzysztof, whose mother-in-law has AD, 
said: „lekarz powiedział, że to nie rozmawiasz 
z matką, ale rozmawiasz z chorobą, z chorym, 
z Alzheimerem praktycznie rozmawiasz. [The 
doctor said that you’re not talking to mother but 
you’re talking to the illness, the ill, you’re prac-
tically talking to the Alzheimer’s.]”. The men-
tioned practitioner applied a clinical perspec-
tive to the situation and reduced the person with 
AD to her illness. He also transferred his under-
standing to the patient’s family. The doctor’s atti-
tude had been, however, shaped by his academic 
education and professional experience. Prepared 
to cure the disease, he omitted the person.
Within a metaclinical perspective, the main fo-
cus would be to acknowledge the value of the 
person, not forgetting to treat the disease. Per-
haps this perspective is to be learnt from fam-
ily carers. Alina, a granddaughter of a person 
with Alzheimer’s disease from the mentioned 
study said that what she wanted to do was to: 
“Zrozumieć i pokochać. To tyle. (…) Zrozumieć 
chorobę i pojąć to, że tego to się już nie da już 
(…), a pokochać babcię, bo ona tego świadoma 
nie jest do końca (…) [Pokochać ją] pomimo tego, 
co robi i co ta choroba robi z nią. [To understand 
and love, that’s all. (…) To understand the ill-
ness and comprehend that it cannot be changed 
(…) and to love grandma, because she isn’t quite 
conscious of that (…). [To love her] in spite of 
what she’s doing and what the illness is doing 
to her.” The metaclinical point of view empha-
sizes that behind the symptoms there is a hu-
man being, a physiological, psychological and 
spiritual entity.
Involving people with AD in research is an im-
portant contribution to shape attitudes, not only 
of researchers themselves but also to all the re-
cipients of their research. Scientific inquiry influ-
ences the social perception of people with Alzhe-
imer’s disease, and is thus capable of reducing 
the stigma of their illness and the fear experi-
enced in encounters with people with neurode-
generative diseases. The metaclinical perspective 
seems to be the one worth consideration in or-
der to overcome the shortcomings of Alzheim-
er’s disease research.
REFERENCEs
  1. Cotrell V, Schulz R. The perspective of the patient with Alzhe-
imer’s disease: A neglected dimension of dementia research. 
Gerontologist. 1993; 33(2): 205–211.
  2. Gillies B. The experience of living through dementia. Int J 
Geriatr Psychiatry. 2001; 16(1): 111–112.
  3. Kitwood T. The Experience of Dementia. Aging Ment Health. 
1997; 1(1): 13–22.
  4. Mast BT. Uncertainties in dementia: What do people with de-
mentia experience. Generations – Journal of the American 
Society on Aging. 2009; 33(1): 30–37.
  5. Ohman A, Josephsson S, nygård L. Awareness through in-
teraction in everyday occupations: experiences of people 
with Alzheimer’s disease. Scand J Occup Ther. 2008; 15(1): 
43–51.
  6. nolan M, Ryan T, Enderby P, Reid D. Towards a more Inclu-
sive vision of dementia care practice and research. Demen-
tia. 2002; 1(2): 193–211.
  7. Adams T, Gardiner P. Communication and interaction within 
dementia care triads: Developing a theory for relationship-
centred care. Dementia. 2005; 4(2): 185–205.
  8. The International Longevity Centre, 2011.
  9. Beuscher L, Grando VT. Challenges in conducting qualitative 
research with individuals with dementia. Research in Geron-
tological nursing. 2009; 2(1): 6–11.
10. Hughes JC, Louw SJ, Sabat SR. In: Hughes JC, Louw SJ, 
Sabat SR, editors. Dementia: mind, meaning and the person. 
Oxford: Oxford University Press; 2006. p. 1–39.
11. Arendt H. The Human Condition, 5th ed. Chicago, Illinois: 
The University of Chicago Press; 1998.
12. de Boer ME, Hertogh CMPM, Dröes R-M, Riphagen II, Jonk-
er C, Eefsting JA. Suffering from dementia – the patient’s per-
spective: a review of the literature. Int Psychogeriatr. 2007; 
19(6): 1021–1039.
13. Guinn DE. Mental competence, caregivers, and the process 
of consent: Research involving Alzheimer’s patients or oth-
ers with decreasing mental capacity. Camb Q Healthc Eth-
ics. 2002; 11: 230–245.
14. Szczepanowska B. Alzheimer’s disease in Poland. Int J Ger-
iatr Psychiatry. 1997; 12(7): 693–694.
15. Bradford A, Kunik ME, Schulz P, Williams SP, Singh H. 
Missed and delayed diagnosis of dementia in primary care: 
prevalence and contributing factors. Alzheimer’s Disease and 
Associated Disorders. 2009; 23(4): 306–314.
 Why is research involving people with Alzheimer’s disease difficult? 47
Archives of Psychiatry and Psychotherapy, 2012; 2 : 41–47
16. Robinson L, Clare L, Evans K. Making sense of dementia 
and adjusting to loss: psychological reactions to a diagno-
sis of dementia in couples. Aging Ment Health. 2005; 9(4): 
337–347.
17. Pia L, Conway PM. Anosognosia in Alzheimer’s disease. 
Brain Impairment. 2008; 9(1): 22–27.
18. Gadamer HG. Truth and Method, 2nd rev. ed. new York: 
Crossroad; 2004.
19. nygård L. How can we get access to the experiences of peo-
ple with dementia? Suggestions and reflections. Scand J Oc-
cup Ther. 2006; 13(2): 101–113.
20. Behuniak SM. The living dead? The construction of people 
with Alzheimer’s disease as zombies. Ageing and Society. 
2010; 31(01): 70–92.
21. Bond J, Corner L. Researching dementia: are there unique 
methodological challenges for health services research? 
Ageing and Society. 2001; 21(01): 95–116.
22. Ohman A, Josephsson S, nygård L. Awareness through in-
teraction in everyday occupations: experiences of people 
with Alzheimer’s disease. Scand J Occup Ther. 2008; 15(1): 
43–51.
23. Langdon SA, Eagle A, Warner J. Making sense of dementia 
in the social world: A qualitative study. Soc Sci Med. 2007; 
64(4): 989–1000.
24. Opoczyńska M. Existential approach. In: Pilecka W, editor. 
Psychologia zdrowia dzieci i młodzieży. Krakow, Poland: 
WUJ; 2011. p. 84–96.
25. Frankl V. Homo patiens. Attempt to uncover the sense of suf-
fering. Vienna: Franz Deuticke; 1950.
